Ruiting Wen

Zhanjiang, 524000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

DOCK1 inhibitor Box5 (TFA) suppresses proliferation of AML cell lines and prolongs survival in AML xenograft models.

DOCK1 inhibitor Box5 (TFA) suppresses proliferation of AML cell lines and prolongs survival in AML xenograft models.

Journal: Scientific reports

Published: February 06, 2026

Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single-Cell RNA Sequencing Validation.

Integrative Analysis of Genetic Risk Factors for Acute Myeloid Leukemia Using Mendelian Randomization and Single-Cell RNA Sequencing Validation.

Journal: International journal of genomics

Published: January 09, 2026

Therapeutic Drug Monitoring-Guided Antifungal Therapy Under Tyrosine Kinase Inhibitor Treatment in an Advanced Osteosarcoma Patient with Invasive Pulmonary Aspergillosis.

Therapeutic Drug Monitoring-Guided Antifungal Therapy Under Tyrosine Kinase Inhibitor Treatment in an Advanced Osteosarcoma Patient with Invasive Pulmonary Aspergillosis.

Journal: Infection and drug resistance

Published: June 28, 2025

Identification and validation of three tumor suppressors associated with the immune response of acute myeloid leukemia.

Identification and validation of three tumor suppressors associated with the immune response of acute myeloid leukemia.

Journal: Frontiers in genetics

Published: June 23, 2025

Predictive Performance of Bayesian Dosing Software for Vancomycin in Intensive Care Unit Patients.

Predictive Performance of Bayesian Dosing Software for Vancomycin in Intensive Care Unit Patients.

Journal: Therapeutic drug monitoring

Published: July 24, 2024

Association of MTHFR gene polymorphisms with non-Hodgkin lymphoma risk: Evidence from 31 articles.

Association of MTHFR gene polymorphisms with non-Hodgkin lymphoma risk: Evidence from 31 articles.

Journal: Journal of Cancer

Published: June 06, 2024

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering.

Identification and validation of a prognostic risk-scoring model for AML based on m7G-associated gene clustering.

Journal: Frontiers in oncology

Published: September 24, 2023

The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression.

The RNA m6A Reader YTHDF1 Is Required for Acute Myeloid Leukemia Progression.

Journal: Cancer research

Published: December 13, 2021

Cellular immune dysregulation in the pathogenesis of immune thrombocytopenia.

Cellular immune dysregulation in the pathogenesis of immune thrombocytopenia.

Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis

Published: January 25, 2020

Preparation and in vivo pharmacokinetics of rhGH-loaded PLGA microspheres.

Preparation and in vivo pharmacokinetics of rhGH-loaded PLGA microspheres.

Journal: Pharmaceutical development and technology

Published: November 14, 2018

Development and evaluation of LAMP, CPA and IMSA methods for rapid detection of the AML1/ETO fusion gene in acute myeloid leukemia.

Development and evaluation of LAMP, CPA and IMSA methods for rapid detection of the AML1/ETO fusion gene in acute myeloid leukemia.

Journal: Experimental and therapeutic medicine

Published: February 17, 2018

Rho-kinase inhibitor prevents acute injury against transient focal cerebral ischemia by enhancing the expression and function of GABA receptors in rats.

Rho-kinase inhibitor prevents acute injury against transient focal cerebral ischemia by enhancing the expression and function of GABA receptors in rats.

Journal: European journal of pharmacology

Published: September 27, 2016

Showing 1-12 of 12

Last Updated: 09/26/2026